Herophilus Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
Herophilus General Information
Description
Provider of drug discovery services intended for complex brain diseases. The company offers a neurotherapeutics platform, brain organoid modeling, phenotypic screening, disease modeling, biological data analysis, and therapeutic candidate identification, enabling pharmaceutical firms to discover novel treatments for neurological and psychiatric disorders through the combination of human brain models and machine learning.
Contact Information
Website
www.herophilus.com(Operating Subsidiary)
Corporate Office
- 1405 Minnesota Street
- San Francisco, CA 94107
- United States
Corporate Office
- 1405 Minnesota Street
- San Francisco, CA 94107
- United States
Herophilus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 27-Sep-2023 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 20-Jul-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series 1) | 11-Dec-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 12-Sep-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 11-Apr-2017 | $5M | $5.1M | Completed | Generating Revenue | |
| 1. Seed Round | 27-Mar-2017 | $100K | $100K | Completed | Generating Revenue |
Herophilus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 1 |
Herophilus Comparisons
Industry
Financing
Details
Herophilus Competitors (15)
One of Herophilus’s 15 competitors is CuraSen, a Venture Capital-Backed company based in San Carlos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CuraSen | Venture Capital-Backed | San Carlos, CA | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Neurogene | Formerly VC-backed | New York, NY | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA |
Herophilus Signals
Herophilus Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 515 Ventures | Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Asseily Ventures | Venture Capital | Minority | ||
| Boom Capital Ventures | Venture Capital | Minority | ||
| CRV | Venture Capital | Minority |
Herophilus FAQs
-
When was Herophilus founded?
Herophilus was founded in 2017.
-
Where is Herophilus headquartered?
Herophilus is headquartered in San Francisco, CA.
-
What is the size of Herophilus?
Herophilus has 17 total employees.
-
What industry is Herophilus in?
Herophilus’s primary industry is Drug Discovery.
-
Is Herophilus a private or public company?
Herophilus is a Private company.
-
What is Herophilus’s current revenue?
The current revenue for Herophilus is .
-
How much funding has Herophilus raised over time?
Herophilus has raised $37.1M.
-
Who are Herophilus’s investors?
515 Ventures, Alexandria Venture Investments, Asseily Ventures, Boom Capital Ventures, and CRV are 5 of 14 investors who have invested in Herophilus.
-
Who are Herophilus’s competitors?
CuraSen, Neurona Therapeutics, NeuroNascent, Neurogene, and Minerva Neurosciences are some of the 15 competitors of Herophilus.
-
When was Herophilus acquired?
Herophilus was acquired on 27-Sep-2023.
-
Who acquired Herophilus?
Herophilus was acquired by Genentech Roche.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process